Monoclonal antibody and anthracycline antibiotic

This page covers all Monoclonal antibody and anthracycline antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD20.

Targets

CD20

Phase 2 pipeline (1)

• R-CHOP with doxorubicin · Fondazione Italiana Linfomi - ETS · Oncology
  Rituximab targets CD20 on B cells, doxorubicin is an anthracycline antibiotic that intercalates DNA and inhibits topoisomerase II.

Patent intelligence

• monoclonal antibody and anthracycline antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates